Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03205605 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
NCT03205605: Completed Early Phase 1 study, sponsored by University of Maryland, Baltimore.
NCT03205605 is a Early Phase 1 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 13 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03205605, a Early Phase 1 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
This research study is intended to determine the effect of heat and occlusion on oxybutynin products.
Primary Outcome
Cmax (oxybutynin) during first heat period for patch (24-25.5 h)
Interventions
- DRUG oxybutynin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2019-11-13 |
| Phase | Early Phase 1 |
What the finished NCT03205605 record still lists
NCT03205605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 1 intervention - of which oxybutynin is the first listed.
NCT03205605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03205605 about?
NCT03205605 is a clinical study titled "Effect of Heat on Oxybutynin Release and Absorption From Oxybutynin Products". This research study is intended to determine the effect of heat and occlusion on oxybutynin products.
What is the current status of trial NCT03205605?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2018-01-02. Estimated completion is 2019-11-13.
What interventions are being tested in trial NCT03205605?
The interventions under investigation include: oxybutynin (DRUG).
Who is sponsoring clinical trial NCT03205605?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03205605's enrollment target sits among peer trials
13 1504th of 2000 higher than 472 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI